Presentation is loading. Please wait.

Presentation is loading. Please wait.

Survival of subjects listed for heart transplantation with and without spirometry. Survival of subjects listed for heart transplantation with and without.

Published byInge Makmur Modified over 4 years ago

Similar presentations

Presentation on theme: "Survival of subjects listed for heart transplantation with and without spirometry. Survival of subjects listed for heart transplantation with and without."— Presentation transcript:

1 Survival of subjects listed for heart transplantation with and without spirometry.
Survival of subjects listed for heart transplantation with and without spirometry. A: Kaplan-Meier estimates for the primary outcome (death and left ventricular assist device implantation). B: Kaplan-Meier estimates for the secondary outcome (death, urgent transplantation, and left ventricular assist device implantation). Vasiliki V Georgiopoulou et al. Respir Care 2015;60: (c) 2012 by Daedalus Enterprises, Inc.

Download ppt "Survival of subjects listed for heart transplantation with and without spirometry. Survival of subjects listed for heart transplantation with and without."

Similar presentations

Effect of nasal positive expiratory pressure (PEP) on 6-min walk test (6MWT) distance and pre- to post-exercise increase in lung volumes in each individual.

Effect of nasal positive expiratory pressure (PEP) on 6-min walk test (6MWT) distance and pre- to post-exercise increase in lung volumes in each individual.
Jennifer A. Cowger, MD, Matthew A

Jennifer A. Cowger, MD, Matthew A
Copyright © 2017 American Academy of Pediatrics.

Copyright © 2017 American Academy of Pediatrics.
Age-related cumulative incidence for (A) serious adverse events (including death, heart failure admission, ventricular arrhythmia and cardiac transplant)

Age-related cumulative incidence for (A) serious adverse events (including death, heart failure admission, ventricular arrhythmia and cardiac transplant)
The changes in peak flow and inspiratory time between a minimum rise time (first 2 breaths) and a maximum rise time (last 2 breaths), with the Servo-i.

The changes in peak flow and inspiratory time between a minimum rise time (first 2 breaths) and a maximum rise time (last 2 breaths), with the Servo-i.
Mask fit process. Mask fit process. The mask fit process begins with 3-dimensional surface images of the subject's face (A). Three-dimensional scans are.

Mask fit process. Mask fit process. The mask fit process begins with 3-dimensional surface images of the subject's face (A). Three-dimensional scans are.
Spearman rank correlation between absolute humidity and the patient's core temperature with the Humid-Heat device. Spearman rank correlation between absolute.

Spearman rank correlation between absolute humidity and the patient's core temperature with the Humid-Heat device. Spearman rank correlation between absolute.
Matrix used to calculate the kappa statistic.

Matrix used to calculate the kappa statistic.
David F. Katz et al. JACEP 2016;j.jacep

David F. Katz et al. JACEP 2016;j.jacep
Wayne L. Miller et al. JCHF 2013;1:

Wayne L. Miller et al. JCHF 2013;1:
Giuseppe Boriani et al. JACEP 2016;2:

Giuseppe Boriani et al. JACEP 2016;2:
Mohit K. Turagam et al. JACEP 2017;3:

Mohit K. Turagam et al. JACEP 2017;3:
Svend A. Mortensen et al. JCHF 2014;2:

Svend A. Mortensen et al. JCHF 2014;2:
Enrollment and Outcomes

Enrollment and Outcomes
Picture of bubble PEP devices.

Picture of bubble PEP devices.
Should Patients 60 Years and Older Undergo Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices?  Jeremiah G. Allen, MD, Arman.

Should Patients 60 Years and Older Undergo Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices?  Jeremiah G. Allen, MD, Arman.
David F. Katz et al. JACEP 2017;3:20-28

David F. Katz et al. JACEP 2017;3:20-28
Neal A. Chatterjee et al. JCHF 2014;2:

Neal A. Chatterjee et al. JCHF 2014;2:
Outcomes on Continuous Flow Left Ventricular Assist Devices: A Single Institutional 9- Year Experience  Jeffrey A. Morgan, MD, Pauline H. Go, MD, Linnea.

Outcomes on Continuous Flow Left Ventricular Assist Devices: A Single Institutional 9- Year Experience  Jeffrey A. Morgan, MD, Pauline H. Go, MD, Linnea.
(A) Kaplan-Meier curve showing AF-free survival after a single procedure for patients grouped according to use of CT integration. (A) Kaplan-Meier curve.

(A) Kaplan-Meier curve showing AF-free survival after a single procedure for patients grouped according to use of CT integration. (A) Kaplan-Meier curve.

Similar presentations

Ads by Google